1. Academic Validation
  2. PCGF6/MAX/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter

PCGF6/MAX/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter

  • Epigenetics Chromatin. 2023 Mar 9;16(1):9. doi: 10.1186/s13072-023-00483-w.
Meng Zhu 1 Ruo-Nan Zhang 2 Hong Zhang 1 Chang-Bao Qu 1 Xiao-Chong Zhang 3 Li-Xin Ren 1 Zhan Yang 1 4 Jun-Fei Gu 5
Affiliations

Affiliations

  • 1 Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China.
  • 2 School of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
  • 3 Clinical Laboratory, Xingtai People's Hospital, Xingtai, China.
  • 4 Molecular Biology Laboratory, Talent and Academic Exchange Center, The Second Hospital of Hebei Medical University, Shijiazhang, China.
  • 5 Department of Urology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, China. gujunfeiey@163.com.
Abstract

Polycomb group RING finger protein 6 (PCGF6) plays an important role as a regulator of transcription in a variety of cellular processes, including tumorigenesis. However, the function and expression of PCGF6 in papillary RCC (pRCC) remain unclear. In the present study, we found that PCGF6 expression was significantly elevated in pRCC tissues, and high expression of PCGF6 was associated with poor survival of patients with pRCC. The overexpression of PCGF6 promoted while depletion of PCGF6 depressed the proliferation of pRCC cells in vitro. Interestingly, myc-related zinc finger protein (MAZ), a downstream molecular of PCGF6, was upregulated in pRCC with hypomethylation promoter. Mechanically, PCGF6 promoted MAZ expression by interacting with MAX and KDM5D to form a complex, and MAX recruited PCGF6 and KDM5D to the CpG island of the MAZ promoter and facilitated H3K4 histone demethylation. Furthermore, CDK4 was a downstream molecule of MAZ that participated in PCGF6/MAZ-regulated progression of pRCC. These results indicated that the upregulation of PCGF6 facilitated MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the MAZ promoter. The PCGF6/MAZ/CDK4 regulatory axis may be a potential target for the treatment of ccRCC.

Keywords

Hypomethylation; Myc-related zinc finger protein; PCGF6; Papillary renal cell carcinoma.

Figures
Products